共 50 条
2020 Korean Society of Myocardial Infarction Expert Consensus Document on Pharmacotherapy for Acute Myocardial Infarction
被引:15
|作者:
Kim, Hyun Kuk
[1
]
Ahn, Youngkeun
[2
]
Chang, Kiyuk
[3
]
Jeong, Young-Hoon
[4
,5
]
Hahn, Joo-Yong
[6
]
Choo, Eun Ho
[3
]
Kim, Min Chul
[2
]
Kim, Hyo-Soo
[7
,8
]
Kim, Weon
[9
]
Cho, Myeong-Chan
[10
]
Jang, Yangsoo
[11
]
Kim, Chong Jin
[12
]
Jeong, Myung Ho
[2
]
Chae, Shung Chull
[13
,14
]
机构:
[1] Chosun Univ, Dept Internal Med, Coll Med, Gwangju, South Korea
[2] Chonnam Natl Univ Hosp, Dept Cardiol, 42 Jebong Ro, Gwangju 61469, South Korea
[3] Catholic Univ Korea, Dept Internal Med, Div Cardiol, Seoul St Marys Hosp, Seoul, South Korea
[4] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Chang Won, South Korea
[5] Gyeongsang Natl Univ, Cardiovasc Ctr, Changwon Hosp, Chang Won, South Korea
[6] Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc & Stroke Inst, Sch Med, Seoul, South Korea
[7] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea
[8] Seoul Natl Univ Hosp, Cardiovasc Ctr, Seoul, South Korea
[9] Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Internal Med, Div Cardiovasc, Seoul, South Korea
[10] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea
[11] Yonsei Univ, Cardiovasc Res Inst, Cardiol Div, Coll Med, Seoul, South Korea
[12] Kyung Hee Univ Hosp Gangdong, Cardiovasc Ctr, Seoul, South Korea
[13] Kyungpook Natl Univ Hosp, Dept Internal Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea
[14] Kyungpook Natl Univ, Sch Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea
关键词:
Myocardial infarction;
Drug therapy;
ST-SEGMENT-ELEVATION;
PERCUTANEOUS CORONARY INTERVENTION;
DUAL ANTIPLATELET THERAPY;
CONVERTING ENZYME-INHIBITORS;
TYPE-1 RECEPTOR BLOCKERS;
STATIN THERAPY;
UNFRACTIONATED HEPARIN;
CARDIOVASCULAR EVENTS;
FIBRINOLYTIC THERAPY;
PRIMARY ANGIOPLASTY;
D O I:
10.4070/kcj.2020.0196
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Clinical practice guidelines published by the European Society of Cardiology and the American College of Cardiology/American Heart Association summarize the available evidence and provide recommendations for health professionals to enable appropriate clinical decisions and improve clinical outcomes for patients with acute myocardial infarction (AMI). However, most current guidelines are based on studies in non-Asian populations in the pre-percutaneous coronary intervention (PCI) era. The Korea Acute Myocardial Infarction Registry is the first nationwide registry to document many aspects of AMI from baseline characteristics to treatment strategies. There are well-organized ongoing and published randomized control trials especially for antiplatelet therapy among Korean patients with AMI. Here, members of the Task Force of the Korean Society of Myocardial Infarction review recent published studies during the current PCI era, and have summarized the expert consensus for the pharmacotherapy of AMI.
引用
收藏
页码:845 / 866
页数:22
相关论文